COMMUNIQUÉS West-GlobeNewswire

Guerbet : H1 2026 revenue.
23/07/2026
H1 2026 revenue H1 activity Revenue of €379.2m at 30 June 2026, nearly stable at CER 1 and on a like-for-like basis 2 (-0.1%) A 2.5% decline in Q2 at CER and on a like-for-like basis, marked by a solid recovery in the [...]
UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026
23/07/2026
SAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2026 results on Thursday, August 6, [...]
Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships
23/07/2026
New Taipei City, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization [...]
Aeroflow Health’s Independent Research Identifies Why Mothers Miss Postpartum Care and What Health Plans Can Do About It
23/07/2026
Aeroflow’s research provides health plans with key insights into why new mothers miss the vital six-week postpartum visit ASHEVILLE, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a technology-enabled [...]
First American Equipment Finance renews HFMA Peer Review designation
23/07/2026
CHICAGO, July 23, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, First American Equipment Finance has once again achieved the “Peer [...]
HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
23/07/2026
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b HCW11-018b has demonstrated potential for treating [...]
Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201
23/07/2026
Orphan designation provides market exclusivity and development benefits in the European Union as both programs advance in global pivotal clinical trials DURHAM, N.C., July 23, 2026 (GLOBE NEWSWIRE) -- Atsena [...]
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
23/07/2026
Taipei, Taiwan, July 23, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform
23/07/2026
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications THE WOODLANDS, TX, [...]
Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka
23/07/2026
New spirits line brings the bold blood orange and honey profile of Revolver’s iconic Blood & Honey beer to Whiskey, Gin and Vodka launching exclusively in Texas BRECKENRIDGE, Colo., July 23, 2026 (GLOBE NEWSWIRE [...]
BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches
23/07/2026
LAS VEGAS, July 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a developer of science-driven wellness products, today announces the successful completion of its commercial manufacturing and [...]
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
23/07/2026
First global approval of a once-daily, orally administered, Complement Factor B inhibitor Approval based on robust efficacy and safety data from Haisco's broad completed clinical development program in PNH Ciprocopan [...]
Indivior to Report Second Quarter 2026 Financial Results and Host Webcast
23/07/2026
RICHMOND, Va., July 23, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its second quarter 2026 financial results on Tuesday, August 4, 2026, at 7:00 a.m. U.S. [...]
IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development
23/07/2026
Translational and clinical data reinforce IMNN-001's potential to unlock IL-12's anti-tumor power in ovarian cancer within a highly safe, proprietary mechanism First-of-its-kind meeting spotlights IMNN-001 as one of the [...]
ApolloMD Earns National and Atlanta Best and Brightest Companies to Work For® Honors for Second Straight Year
23/07/2026
ATLANTA, July 23, 2026 (GLOBE NEWSWIRE) -- ApolloMD has been named one of the 2026 Best and Brightest Companies to Work For ® both nationally and in Atlanta for the second consecutive year, recognizing continued [...]
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
23/07/2026
Dr. Ascheim has over 30 years of clinical and executive experience advancing breakthrough therapies, including gene, cell, and biologics MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) a clinical [...]
Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026
23/07/2026
SALT LAKE CITY, July 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2026 earnings conference call at 4: [...]
Intuitive Shares Vision for an AI-Enabled Future of Healthcare
23/07/2026
Company outlines five-layer AI framework to help address healthcare’s biggest challenges and demonstrates real-time telesurgical collaboration between California and Georgia SUNNYVALE, Calif., July 23, 2026 (GLOBE [...]
Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
23/07/2026
SAN JOSE, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]

Pages